ProCE Banner Series

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2024 Oncology Meeting in Chicago

Join us for this live, interactive webinar to hear experts discuss some of the most impactful abstracts presented during the ASCO Annual Meeting and answer audience questions on the data. Full details on the available topics are provided below.

  AMA
Who Should Attend

This program is intended for oncologists and other healthcare professionals caring for patients with cancer.

All Events

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2024 Oncology Meeting in Chicago

Past Events

June

22

2024

8:00 AM - 4:15 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Allison Betof Warner, MD, PhD

Assistant Professor of Medicine (Oncology)
Director, Melanoma Medical Oncology Program
Director, Solid Tumor Cellular Therapy 
Leader, Melanoma & Cutaneous Oncology Clinical Research Group
Stanford University School of Medicine
Stanford, California

ProCE Banner Faculty
Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

ProCE Banner Faculty
Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

ProCE Banner Faculty
Rana R. McKay, MD

Associate Professor of Medical Oncology and Urology
Associate Director, Clinical Sciences
Co-Lead, Genitourinary Malignancies Program
Moores Cancer Center
University of California San Diego
La Jolla, California

ProCE Banner Faculty
Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

ProCE Banner Faculty
Jeffrey P. Sharman, MD

Medical Director of Hematology Research
Sarah Cannon at Willamette Valley Cancer Institute
Eugene, Oregon

ProCE Banner Faculty
Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Topics

Breast cancers

Genitourinary cancers

Leukemia

Lymphoma

Multiple myeloma

Lung cancers

Skin cancers

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve learners’ understanding of how to optimally apply recent practice-changing findings in treating patients with solid tumors or hematologic malignancies.

Target Audience
This program is intended for oncologists and other healthcare professionals caring for patients with cancer. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify subpopulations of patients with solid tumors or hematologic malignancies most likely to benefit from a specific treatment plan based on predictive biomarkers
  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with solid tumors or hematologic malignancies
  • Evaluate new data on novel agents and therapeutic approaches for patients with solid tumors or hematologic malignancies

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Hematologic Malignancies - 1.5
  • Breast Cancer - 1.0
  • Lung Cancer - 1.0
  • Skin Cancer - 1.0
  • Genitourinary cancers - 1.0 

CME Passport

A logo for a companyDescription automatically generated

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Breast Cancer topic:
Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Novartis Pharmaceuticals Corporation.

Hematologic Malignancies topic:
Supported by educational grants from GSK, Lilly, Novartis Pharmaceuticals Corporation, and Sanofi.

Lung Cancer topic:
Supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; and Gilead Sciences, Inc.

Skin Cancer topic:
Supported by an educational grant from Merck Sharp & Dohme LLC.

Genitourinary Cancer topic:
Supported by an educational grant from Novartis Pharmaceuticals Corporation.